Using genetics to understand causal mechanisms underlying adverse outcomes of obese pregnancies
In plain English
AI plain-English summaryMore than one in five pregnant women in the UK are clinically obese, yet doctors cannot predict which of them will develop complications like gestational diabetes or preterm birth. Current studies struggle to untangle why a high maternal BMI leads to such different outcomes for different women. This research uses human genetics to trace causal pathways, rather than just observing associations. The key idea is that the fetus’s own genes may moderate how it responds to the mother’s obesity—influencing its growth, the timing of birth, and even the mother’s metabolic environment. The researcher will apply new genome-wide studies of placental weight and umbilical cord insulin to reveal these mechanisms. If successful, the work could allow clinicians to stratify pregnant women by actual risk, rather than treating all obese pregnancies the same. That would mean better-targeted antenatal care and advice, reducing the incidence of adverse outcomes without unnecessary interventions for low-risk women. This is fundamental science with a clear translational goal: turning genetic insight into practical, personalised pregnancy management.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Senior Research FellowshipPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know